Skip to Main Content

Paper Details

Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.
Proc Natl Acad Sci U S A
160
2010
HDAC, HDAC1, HDAC2, RNA, fetal hemoglobin, fetal hemoglobin transcripts, hemoglobin, histone deacetylase, histone deacetylase 1, human, primary human erythroid cells, sickle cell disease
Author NameAffiliation
James E BradnerBroad Institute of Harvard and Massachusetts Institute Technology
  • 1 - 1

Datasets

Release 1.2